New Organization to Preserve and Expand Access to Quality Care with Geographically Complementary Facilities Across 28 StatesContinue reading→

Breezing, GT Medical Technologies, Life365, and Resonea are finalists for the Fall Arizona Innovation Challenge.Continue reading→

Novel formulation of partial opioid offers potential benefits compared to current alternatives

Continue reading→

DxNA LLC receives a de novo regulatory clearance by the FDA for the GeneSTAT.MDx™ Coccidioides Test on the GeneSTAT® Analyzer – the only FDA cleared molecular test for Valley Fever

With technology developed by TGen, the test allows for rapid definitive diagnosis of Valley FeverContinue reading→

After a national search, biomedical engineer Jennifer Kehlet Barton has been named director of the BIO5 Institute.

BIO5 is a universitywide institute that brings together researchers from across the five main bioscience disciplines – agriculture, bioengineering, biomedicine, pharmacy and basic science – to develop creative, bold solutions to humanity’s most pressing health and environmental challenges.Continue reading→

Researchers have discovered a key player in the molecular process that causes the communication breakdown between nerves in fatal muscle degeneration disease.Continue reading→

TUCSON, AZ, and DOWNINGTOWN, PA – December 4, 2017 –Critical Path Institute‘s (C-Path) Data Collaboration Center (DCC) and the Friedreich’s Ataxia Research Alliance (FARA) have announced that they will work together to develop an aggregated database of clinical data for Friedreich’s ataxia (FA). Use of this database will promote collaborative research to support the understanding of natural history, potential biomarkers, and potential clinical endpoints for patients with FA, which will help researchers develop more efficient clinical trial protocols to test new therapies more quickly and effectively.Continue reading→